User profiles for Takeshi Ishikawa

Takeshi Ishikawa

- Verified email at koto.kpu-m.ac.jp - Cited by 10947

Takeshi Ishikawa

- Verified email at cb.kagoshima-u.ac.jp - Cited by 2102

Theoretical study on the photoisomerization of azobenzene

T Ishikawa, T Noro, T Shoda - The Journal of Chemical Physics, 2001 - pubs.aip.org
Ab initio calculations are performed to elucidate the mechanism of the photoisomerization of
azobenzene. We obtain the excitation energies of the S 1 (n→π * ), S 2 (π→π * ), and S 3 (n …

Silver nanoparticles as a safe preservative for use in cosmetics

S Kokura, O Handa, T Takagi, T Ishikawa… - … , Biology and Medicine, 2010 - Elsevier
Concern is continuously raised regarding the safety of preservatives, which are crucial in
most cosmetic preparations. The antimicrobial effects of silver (Ag) are well recognized; …

Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects

…, O Dohi, N Yoshida, K Kamada, T Ishikawa… - Journal of …, 2019 - Springer
Background Human gut microbiota is involved in host health and disease development.
Investigations of age-related and sex-related alterations in gut microbiota are limited, and the …

Flow patterns and mixing mechanisms in the screw mixing element of a co‐rotating twin‐screw extruder

T Ishikawa, T Amano, SI Kihara… - Polymer Engineering & …, 2002 - Wiley Online Library
Non‐Newtonian and non‐isothermal flow simulations based on 3‐D FEM were applied to a
special and conventional elements of a twin‐screw extruder. The screw mixing element (SME…

Solvent selection for pharmaceuticals

P Kolář, JW Shen, A Tsuboi, T Ishikawa - Fluid Phase Equilibria, 2002 - Elsevier
The presence of solvents is essential in all steps of pharmaceutical processes (reaction,
separation, and formulation). For toxicological reasons, drug manufacturers are increasingly …

[HTML][HTML] Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

N Sakamoto, T Ishikawa, S Kokura, T Okayama… - Journal of translational …, 2015 - Springer
Background NK cells can destroy tumor cells without prior sensitization or immunization.
Tumors often lose expression of MHC molecules and/or antigens. However, NK cells can lyse …

Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer

…, M Ishihara, K Saito, S Sugino, S Ueda, T Ishikawa… - Clinical Cancer …, 2015 - AACR
Purpose: Preparative lymphodepletion, the temporal ablation of the immune system, has
been reported to promote persistence of transferred cells along with increased rates of tumor …

Computer-aided molecular design with combined molecular modeling and group contribution

PM Harper, R Gani, P Kolar, T Ishikawa - Fluid Phase Equilibria, 1999 - Elsevier
Computer-aided molecular design (CAMD) provides a means for determining molecules or
mixtures of molecules (CAMMD) having a desirable set of physicochemical properties. The …

Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor‐alpha deficient mice

Y Naito, T Takagi, O Handa, T Ishikawa… - Journal of …, 2003 - Wiley Online Library
Background and Aims: Tumor necrosis factor‐α (TNF‐α) is a potent pro‐inflammatory
cytokine thought to be involved in the pathogenesis of inflammatory bowel disease. To further …

Theoretical study of the prion protein based on the fragment molecular orbital method

T Ishikawa, T Ishikura, K Kuwata - Journal of computational …, 2009 - Wiley Online Library
We performed fragment molecular orbital (FMO) calculations to examine the molecular
interactions between the prion protein (PrP) and GN8, which is a potential curative agent for prion …